埃索美拉唑(耐信)去哪买

Nexium is an alias for Nexium, currently also known as esomeprazole. It is mainly used to inhibit the secretion of gastric acid. It was first approved for marketing in 2000. Its indications so far include gastroesophageal reflux disease (GERD) and the eradication of Helicobacter pylori when combined with appropriate antibacterial therapy.

Gastric acid is a key factor in maintaining the function of the upper gastrointestinal tract, but abnormal gastric acid levels may lead to the emergence of a variety of diseases, such as heartburn, gastric ulcers, etc., affecting the patient's health. Therefore, the first proton pump inhibitor that inhibits gastric acid secretion, omeprazole, was developed and marketed. Esomeprazole was AstraZeneca's further research on the basis of omeprazole and separated it into the S-isomer, which is more effective than omeprazole.

Where to buy esomeprazole (Nexium)?

Due to its good effects and low side effects, esomeprazole became one of the best-selling drugs in the world once it was launched, and was also called a "blockbuster". At present, esomeprazole (Nexium) has been launched in China. If patients need this drug, they can buy it at domestic prescriptions or hospitals. It is more convenient to purchase. However, the price of AstraZeneca's original drug is still relatively high. In comparison, esomeprazole produced by SUN in India is more cost-effective.

The specifications of the Indian version (Nexium) are 40mg*150 capsules, and the price is equivalent to RMB 520. The price may change due to various factors such as exchange rates. Please consult the medical companion passenger service for details. There are usually two ways to buy the Indian version of esomeprazole. One is to go to a regular pharmacy in India to buy it in person, so you don’t have to worry about buying fake drugs. The second is to purchase through domestic professional overseas medical consulting service companies (such as Medical Travel) to ensure that you buy genuine drugs.

Recommended related hot articles: /newsDetail/79774.html